SD-1008

1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

SD-1008 is a potent JAK inhibitor. SD-1008 inhibits tyrosyl phosphorylation of STAT3, JAK2 and Src. SD-1008 also reduces STAT3-dependent luciferase activity. SD-1008 enhances apoptosis induced by Paclitaxel in ovarian cancer cells via directly blocking the JAK-STAT3 signaling pathway.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.10%
  • CAS. Nr.: 960201-81-4
  • Formel: C18H19NO5
  • Molecular Weight:329.35
  • Speicherung:

    -20°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) SD-1008

More

Alle JAK Isoform-spezifische Produkte anzeigen

More

Alle STAT Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00